ProtoKinetix, Incorporated (PKTX)
OTCMKTS · Delayed Price · Currency is USD
0.0054
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
ProtoKinetix Company Description
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).
Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas.
The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003.
ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.
ProtoKinetix, Incorporated
| Country | United States |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Clarence Smith |
Contact Details
Address: 109 W Main St Dalton, Nevada 44618 United States | |
| Phone | 330 455 4971 |
| Website | protokinetix.com |
Stock Details
| Ticker Symbol | PKTX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US7437221002 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Clarence Edward Smith | Chairman, President and Chief Executive Officer |
| Michael Richard Guzzetta CPA | Chief Financial Officer |